Latest Financing Round Will Support Tessera’s Build Out of its GENE WRITING Platforms and Pursuit of Multiple Therapeutic Programs for Clinical Development SOMERVILLE, Mass.--(BUSINESS WIRE)--Tessera ...
BOSTON--(BUSINESS WIRE)--Alloy Therapeutics, a biotechnology ecosystem company, has closed $42 million in Series D financing led by its existing investors 8VC and Mubadala Capital and joined by return ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results